hero

Join Us

Discover available job opportunities within our portfolio

Locations

San Carlos, CA, USA · San Francisco, CA, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Series B

founded in

2017

Elegen is a biotechnology company specializing in innovative cell-free DNA synthesis technology, offering ENFINIA DNA, which provides rapid, high-accuracy, long, and complex linear DNA synthesis. Their proprietary technology allows for the production of DNA up to 7 kb in length with an error rate as low as 1:70,000 bp, significantly streamlining workflows in synthetic biology and gene therapy. Elegen's products are designed to eliminate the need for cloning, saving time and costs in various applications, including mRNA vaccine development and biomanufacturing. With a recent $35 million Series B funding round, Elegen is positioned for growth in clinical manufacturing and aims to advance the bioeconomy through innovative DNA manufacturing processes.

Something looks off?
Open jobs at Elegen

On-site & Remote